Zhou Eric S, Clark Karen, Recklitis Christopher J, Obenchain Richard, Loscalzo Matthew
Perini Family Survivors' Center, Dana-Farber Cancer Institute, Boston, MA, USA.
Pediatrics, Harvard Medical School, Boston, MA, USA.
Int J Behav Med. 2018 Oct;25(5):502-516. doi: 10.1007/s12529-018-9715-2.
Cancer patients are likely to experience sleep problems. Understanding their perception of sleep problems is important as subjective symptom experience is associated with treatment-seeking behavior. We explored the prevalence of sleep problems and its correlates in a large sample of cancer patients at an important but understudied stage of their cancer journey: prior to initiating treatment.
Cancer patients (5702) (67.5% female; 76.9% White; 23.0% Hispanic), following diagnosis and prior to initiating cancer treatment, completed an electronic screening instrument. Patients across eight different cancer diagnoses (breast, gastrointestinal, gynecological, head and neck, hematological, lung, prostate, urinary) rated their sleep problems on a five-point scale, with those reporting "severe" or "very severe" sleep problems classified as having high sleep problems.
Overall, 12.5% of patients reported high sleep problems. Across diagnoses, the proportion of patients reporting high sleep problems ranged from 4.3 to 13.8%, with prostate cancer patients least likely and gastrointestinal cancer patients most likely to report high sleep problems. Older age, having a partner, higher education, and higher household income were associated with a lower likelihood of experiencing sleep problems. Being female, Black, Hispanic, and reporting anxiety or depression was associated with an increased likelihood of sleep problems.
A sizeable proportion of cancer patients experience significant problems with their sleep before any treatment has occurred. This clinical issue cannot be ignored as treatment is likely to worsen existing sleep problems. Oncology providers should routinely screen for sleep-related problems. Identifying and treating patients for sleep problems during a vulnerable period early in their cancer trajectory should be an essential component of clinical care.
癌症患者很可能会出现睡眠问题。了解他们对睡眠问题的认知很重要,因为主观症状体验与寻求治疗的行为有关。我们在癌症患者病程中一个重要但研究不足的阶段,即开始治疗之前,对大量癌症患者样本中睡眠问题的患病率及其相关因素进行了探究。
5702名癌症患者(女性占67.5%;白人占76.9%;西班牙裔占23.0%)在确诊后且开始癌症治疗之前,完成了一份电子筛查工具。八种不同癌症诊断类型(乳腺癌、胃肠道癌、妇科癌、头颈癌、血液癌、肺癌、前列腺癌、泌尿系统癌)的患者按照五分制对他们的睡眠问题进行评分,那些报告“严重”或“非常严重”睡眠问题的患者被归类为存在严重睡眠问题。
总体而言,12.5%的患者报告存在严重睡眠问题。在所有诊断类型中,报告存在严重睡眠问题的患者比例在4.3%至13.8%之间,前列腺癌患者报告严重睡眠问题的可能性最小,胃肠道癌患者报告严重睡眠问题的可能性最大。年龄较大、有伴侣、受教育程度较高以及家庭收入较高与出现睡眠问题的可能性较低相关。女性、黑人、西班牙裔以及报告存在焦虑或抑郁与睡眠问题的可能性增加相关。
相当一部分癌症患者在任何治疗开始之前就经历严重的睡眠问题。由于治疗可能会使现有的睡眠问题恶化,所以这个临床问题不能被忽视。肿瘤学提供者应常规筛查与睡眠相关的问题。在癌症病程早期的脆弱阶段识别并治疗患者的睡眠问题应该是临床护理的重要组成部分。